scholarly article | Q13442814 |
P356 | DOI | 10.1136/BMJ.305.6844.28 |
P953 | full work available at URL | https://europepmc.org/articles/PMC1882510 |
https://europepmc.org/articles/PMC1882510?pdf=render | ||
P932 | PMC publication ID | 1882510 |
P698 | PubMed publication ID | 1379094 |
P5875 | ResearchGate publication ID | 21776807 |
P2093 | author name string | R. Stone | |
J. G. Grudzinskas | |||
G. Barkai | |||
B. Teisner | |||
W. Fuhrmann | |||
B. Brambati | |||
H. S. Cuckle | |||
N. Wald | |||
P2860 | cites work | Value of necropsy in acquired immunodeficiency syndrome | Q43609630 |
P433 | issue | 6844 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 28 | |
P577 | publication date | 1992-07-01 | |
1992-07-04 | |||
P1433 | published in | The BMJ | Q546003 |
P1476 | title | First trimester concentrations of pregnancy associated plasma protein A and placental protein 14 in Down's syndrome | |
P478 | volume | 305 |
Q90100849 | A common variant of the pregnancy-associated plasma protein-A (PAPPA) gene encodes a protein with reduced proteolytic activity towards IGF-binding proteins |
Q38170863 | A historical and practical review of first trimester aneuploidy screening |
Q33721476 | A review of risk factors for child pedestrian injuries: are they modifiable? |
Q71598362 | A sensitive enzyme immunoassay for pregnancy-associated plasma protein A (PAPP-A): a possible first trimester method of screening for Down syndrome and other trisomies |
Q37765287 | A timely diagnosis of myocardial infarction. |
Q43828982 | Accuracy of single measurements of pregnancy-associated plasma protein-A, human chorionic gonadotropin and progesterone in the diagnosis of early pregnancy failure |
Q40909255 | Antenatal screening for Down's syndrome. |
Q37801660 | Application of proteomics to prenatal screening and diagnosis for aneuploidies. |
Q52208776 | Appropriate biochemical parameters in first-trimester screening for Down syndrome. |
Q43152691 | Biochemical screening for Down's syndrome |
Q74132225 | Evaluation of first trimester maternal serum and ultrasound screening for Down's syndrome in Eastern and Northern Finland |
Q58136234 | First Trimester Biochemical Screening for Down's Syndrome |
Q38893745 | First trimester combined screening - focus on early biochemistry. |
Q33768998 | First trimester screening for aneuploidy: serum biochemical markers |
Q37208068 | First- and second-trimester Down syndrome screening: current strategies and clinical guidelines. |
Q45291831 | First-trimester Down syndrome screening: free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A. |
Q71620967 | First-trimester biochemical screening for Down syndrome with the use of PAPP-A, AFP, and beta-hCG |
Q72080653 | Low maternal serum levels of pregnancy associated plasma protein A (PAPP‐A) in the first trimester in association with abnormal fetal karyotype |
Q73070410 | Markers for Down's syndrome in early pregnancy |
Q42762495 | Pregnancy associated plasma protein A in Down's syndrome |
Q42984383 | Pregnancy associated plasma protein A in Down's syndrome |
Q84836506 | Prenatal testing for Down syndrome: comparison of screening practices in the UK and USA |
Q36624223 | Present and future biochemical markers for detection of acute coronary syndrome |
Q55014471 | Prognostic value of the Stanniocalcin-2/PAPP-A/IGFBP-4 axis in ST-segment elevation myocardial infarction. |
Q41199161 | Screening for Down's syndrome |
Q72099390 | Serum PAPP‐A levels are depressed in women with fetal Down syndrome in early pregnancy |
Q40584410 | Techniques in current use in prenatal diagnosis. |
Q37470283 | The ethics of antenatal screening: lessons from Canute. |
Q90539086 | The insulin-like growth factor-1 system in the adult mammalian brain and its implications in central maternal adaptation |
Q73083969 | The proform of eosinophil major basic protein: a new maternal serum marker for Down syndrome |
Q35690633 | The role of PAPP-A in the IGF system: location, location, location. |